Incyte (Nasdaq: INCY) has announced that multiple abstracts highlighting data from its oncology portfolio will be presented ...

- Current pipeline of gene therapies for chronic diseases spans three major therapeutic areas: ophthalmology, metabolic ...

Accepted abstracts are available on the ASGCT Annual Meeting website. Presentation details are as follows: Phase 1 Translational Assessment of an Off-The-Shelf CAR NK Cell Armed with Alloimmune ...

Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet ...

VectorY Therapeutics (VectorY), a biotechnology company developing innovative vectorized antibody therapies for the treatment ...

The Department for Promotion of Industry and Internal Trade - Intellectual Property Rights (DPIIT - IPR) in collaboration ...

Instead of only asking what is wrong with individuals, perhaps we should also ask what is wrong with the world they live in ...

FARGO — Two upcoming Alzheimer’s Association webinars will focus on communication and dementia. Alzheimer’s Association ...

Axovia Therapeutics Ltd., a biotechnology company developing therapies to address the genetic causes of blindness and obesity, today announced that Co-Founder ...

SEATTLE, April 28, 2025 (GLOBE NEWSWIRE) -- Shape Therapeutics, a leader in RNA-based gene therapy, today announced the acceptance of multiple abstracts, including two oral presentations, at the ...